Foghorn Therapeutics (FHTX) Return on Assets (2020 - 2026)

Foghorn Therapeutics' Return on Assets history runs 7 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Assets fell 1.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.01%, down 1.0% from the prior year.
• Return on Assets declined to 0.01% in Q1 2026 per FHTX's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2022 and bottomed at 0.01% in Q1 2026.
• The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
• Across the five-year window, Return on Assets climbed 1 bps in 2022 and declined 1 bps in 2025, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2022, then decreased by 27 bps to 0.0% in 2023, then grew by 11 bps to 0.0% in 2024, then tumbled by 186 bps to 0.01% in 2025, then retreated by 29 bps to 0.01% in 2026.
• Per Business Quant, the three latest FHTX Return on Assets figures stand at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).